How Safe Are Biological Agents in Pediatric Rheumatology?
Objective: Biologic therapy has changed the prognosis of patients with rheumatologic disease. Despite all benefits of the biological agents, adverse events may occur due to their long-term use. The aim of this study is to analyze the adverse events observed in pediatric patients who received biologi...
Saved in:
Main Authors: | Emine Nur Sunar Yayla, Çisem Yıldız, Pelin Esmeray Şenol, Nihal Karaçayır, Deniz Gezgin Yıldırım, Sevcan A. Bakkaloğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES Yayincilik
2024-03-01
|
Series: | Turkish Archives of Pediatrics |
Online Access: | https://turkarchpediatr.org/en/how-safe-are-biological-agents-in-pediatric-rheumatology-131632 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
by: Batuhan Küçükali, et al.
Published: (2025-01-01) -
Pediatric rheumatology: a clinical viewpoint
by: Geetha Rajan, et al.
Published: (2017-01-01) -
Panniculitis in pediatric rheumatology practice: experience of a pediatric referral center
by: Luana Silva, et al.
Published: (2025-01-01) -
Measuring Transition Readiness of Patients After Transfer from Pediatric to Adult Care in Rheumatology
by: Ali Yağiz Ayla, et al.
Published: (2024-09-01) -
Radiographs in Pediatric Rheumatology: Where Do We Stand?
by: Deeksha Bhalla, et al.
Published: (2025-01-01)